Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials

OBJECTIVE: As monotherapy is insufficient for some patients, the existing fixed-dose combination (FDC) requires two or more daily administrations with declining adherence. The present study compared the efficacy and safety of netarsudil/latanoprost FDC with monotherapy of its individual components i...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Nachuan, Jiang, Xun, Hao, Meiqi, Fang, Zige, Wei, Yiping, Zhang, Wenxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376331/
https://www.ncbi.nlm.nih.gov/pubmed/35979215
http://dx.doi.org/10.3389/fmed.2022.923308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376331/
https://www.ncbi.nlm.nih.gov/pubmed/35979215
http://dx.doi.org/10.3389/fmed.2022.923308

Ejemplares similares